More than 300 members, representing 42 University departments, are working together to improve the understanding of cancer and to develop new lifesaving procedures in cancer prevention, diagnosis, and treatment. UPMC Hillman Cancer Center research programs range from basic science programs that examine the molecular basis of cancer development and progression in the laboratory, to translational and clinical programs that implement novel laboratory findings into clinical trials in humans, to population-based programs that focus on cancer prevention, epidemiology, and biobehavioral factors in cancer.
Research Program Leaders
| Kathryn Schmitz, PhD, MPH | Interim Director, Associate Director for Population Sciences, and Co-Leader, Biobehavioral Cancer Control Program |
| José P. Zevallos, MD MPH | Interim Deputy Director, Deputy Director |
| Dana Bovbjerg, PhD | Co-Leader, Biobehavioral Cancer Control Program |
| Adam Brufsky, MD, PhD | Co-Leader, Cancer Therapeutics Program |
| Ronald Buckanovich, MD, PhD | Co-Leader, Cancer Biology Program |
| Greg Delgoffe, PhD | Co-Leader, Cancer Immunology and Immunotherapy Program |
| Shou-Jiang (SJ) Gao, PhD | Co-Leader, Cancer Virology Program |
| Haitao Guo, PhD | Co-Leader, Cancer Virology Program |
| James Herman, MD | Co-Leader, Cancer Epidemiology and Prevention Program |
| Steffi Oesterreich, PhD | Co-Leader, Cancer Biology Program |
| Patricia Opresko, PhD | Co-Leader, Genome Stability Program |
| Roddy O’Sullivan, PhD | Co-Leader, Genome Stability Program |
| Peter Wipf, PhD | Co-Leader, Cancer Therapeutics Program |
| Jian-Min Yuan, MD, PhD | Co-Leader, Cancer Epidemiology and Prevention Program |
| Hassane Zarour, MD | Co-Leader, Cancer Immunology and Immunotherapy Program |
